Oral and sublingual immunotherapy for food allergy

World Allergy Organization Journal

A Wesley Burks¹  Uyenphuong H Le¹ 

[1] Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill NC 260 MacNider Hall, CB 7220, Chapel Hill, NC 27599-7220, USA

关键词: Tolerance;    Desensitization;    Sublingual immunotherapy;    Oral immunotherapy;    Food allergy;   

Others  :  1137527
DOI  :  10.1186/1939-4551-7-35

 received in 2014-04-17, accepted in 2014-10-31,  发布年份 2014

【 摘 要 】

IgE-mediated food allergy is a potentially life-threatening allergic disease with an increase in prevalence in developed countries over the past 15 years. Currently, there are no approved forms of therapy and the standard of care is dietary restriction and ready access to emergency medications, such as self-injectable epinephrine and antihistamines. Allergen-specific modalities of treatment currently being studied include oral immunotherapy (OIT) and sublingual immunotherapy (SLIT). Both forms demonstrate the ability to desensitize patients to a variety of specific food allergens and show great promise. However, more research is needed to evaluate the safety and efficacy of OIT and SLIT prior to routine use in clinical practice.

【 授权许可】

   
2014 Le and Burks; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Gupta RS, Springston EE, Warrier MR, Smith B, Kumar R, Pongracic J, Holl JL: The prevalence, severity, and distribution of childhood food allergy in the United States. Pediatrics 2011, 128:e9-e17.
• [2]Boyce JA, Assa'ad A, Burks AW, Jones SM, Sampson HA, Wood RA, Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd-Bredbenner C, Camargo CA Jr, Eichenfield L, Furuta GT, Hanifin JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM, Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP, Schwaninger JM: Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report. J Allergy Clin Immunol 2010, 126:1105-1118.
• [3]Bock SA, Munoz-Furlong A, Sampson HA: Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001, 107:191-193.
• [4]Bock SA, Munoz-Furlong A, Sampson HA: Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol 2007, 119:1016-1018.
• [5]Branum AM, Lukacs SL: Food allergy among children in the United States. Pediatrics 2009, 124:1549-1555.
• [6]Sicherer SH, Munoz-Furlong A, Godbold JH, Sampson HA: US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol 2010, 125:1322-1326.
• [7]Nowak-Wegrzyn A, Sampson HA: Future therapies for food allergies. J Allergy Clin Immunol 2011, 127:558-573. quiz 574-555
• [8]Yu JW, Kagan R, Verreault N, Nicolas N, Joseph L, St Pierre Y, Clarke A: Accidental ingestions in children with peanut allergy. J Allergy Clin Immunol 2006, 118:466-472.
• [9]Akeson N, Worth A, Sheikh A: The psychosocial impact of anaphylaxis on young people and their parents. Clin Exp Allergy 2007, 37:1213-1220.
• [10]Sicherer SH, Noone SA, Munoz-Furlong A: The impact of childhood food allergy on quality of life. Ann Allergy Asthma Immunol 2001, 87:461-464.
• [11]Chehade M, Mayer L: Oral tolerance and its relation to food hypersensitivities. J Allergy Clin Immunol 2005, 115:3-12. quiz 13
• [12]Burks AW, Laubach S, Jones SM: Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 2008, 121:1344-1350.
• [13]Burks AW: Peanut allergy. Lancet 2008, 371:1538-1546.
• [14]Jones SM, Burks AW, Dupont C: State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous. J Allergy Clin Immunol 2014, 133:318-323.
• [15]Burks AW, Jones SM, Wood RA, Fleischer DM, Sicherer SH, Lindblad RW, Stablein D, Henning AK, Vickery BP, Liu AH, Scurlock AM, Shreffler WG, Plaut M, Sampson HA, Consortium of Food Allergy R: Oral immunotherapy for treatment of egg allergy in children. N Engl J Med 2012, 367:233-243.
• [16]Varshney P, Jones SM, Scurlock AM, Perry TT, Kemper A, Steele P, Hiegel A, Kamilaris J, Carlisle S, Yue X, Kulis M, Pons L, Vickery B, Burks AW: A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol 2011, 127:654-660.
• [17]Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW: Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol 2014, 133:468-475. e466
• [18]Jones SM, Pons L, Roberts JL, Scurlock AM, Perry TT, Kulis M, Shreffler WG, Steele P, Henry KA, Adair M, Francis JM, Durham S, Vickery BP, Zhong X, Burks AW: Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol 2009, 124:292-300. 300 e291-297
• [19]Sheikh SZ, Burks AW: Recent advances in the diagnosis and therapy of peanut allergy. Expert Rev Clin Immunol 2013, 9:551-560.
• [20]Mousallem T, Burks AW: Immunology in the Clinic Review Series; focus on allergies: immunotherapy for food allergy. Clin Exp Immunol 2012, 167:26-31.
• [21]Di Rienzo V, Marcucci F, Puccinelli P, Parmiani S, Frati F, Sensi L, Canonica GW, Passalacqua G: Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin Exp Allergy 2003, 33:206-210.
• [22]Vourdas D, Syrigou E, Potamianou P, Carat F, Batard T, Andre C, Papageorgiou PS: Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy 1998, 53:662-672.
• [23]Mempel M, Rakoski J, Ring J, Ollert M: Severe anaphylaxis to kiwi fruit: immunologic changes related to successful sublingual allergen immunotherapy. J Allergy Clin Immunol 2003, 111:1406-1409.
• [24]Enrique E, Malek T, Pineda F, Palacios R, Bartra J, Tella R, Basagana M, Alonso R, Cistero-Bahima A: Sublingual immunotherapy for hazelnut food allergy: a follow-up study. Ann Allergy Asthma Immunol 2008, 100:283-284.
• [25]Enrique E, Pineda F, Malek T, Bartra J, Basagana M, Tella R, Castello JV, Alonso R, de Mateo JA, Cerda-Trias T, San Miguel-Moncin Mdel M, Monzon S, Garcia M, Palacios R, Cistero-Bahima A: Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 2005, 116:1073-1079.
• [26]de Boissieu D, Dupont C: Sublingual immunotherapy for cow’s milk protein allergy: a preliminary report. Allergy 2006, 61:1238-1239.
• [27]Fernandez-Rivas M, Garrido Fernandez S, Nadal JA, de Durana MD D, Garcia BE, Gonzalez-Mancebo E, Martin S, Barber D, Rico P, Tabar AI: Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009, 64:876-883.
• [28]Chin SJ, Vickery BP, Kulis MD, Kim EH, Varshney P, Steele P, Kamilaris J, Hiegel AM, Carlisle SK, Smith PB, Scurlock AM, Jones SM, Burks AW: Sublingual versus oral immunotherapy for peanut-allergic children: a retrospective comparison. J Allergy Clin Immunol 2013, 132:476-478. e472
• [29]Keet CA, Frischmeyer-Guerrerio PA, Thyagarajan A, Schroeder JT, Hamilton RG, Boden S, Steele P, Driggers S, Burks AW, Wood RA: The safety and efficacy of sublingual and oral immunotherapy for milk allergy. J Allergy Clin Immunol 2012, 129:448-455. 455.e441-445
• [30]Fleischer DM, Burks AW, Vickery BP, Scurlock AM, Wood RA, Jones SM, Sicherer SH, Liu AH, Stablein D, Henning AK, Mayer L, Lindblad R, Plaut M, Sampson HA, Consortium of Food Allergy R: Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol 2013, 131:119-127. e111-117
• [31]Sampson HA: Peanut oral immunotherapy: is it ready for clinical practice? J Allergy Clin Immunol Pract 2013, 1:15-21.
• [32]Wasserman RL, Factor JM, Baker JW, Mansfield LE, Katz Y, Hague AR, Paul MM, Sugerman RW, Lee JO, Lester MR, Mendelson LM, Nacshon L, Levy MB, Goldberg MR, Elizur A: Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions. J Allergy Clin Immunol Pract 2014, 2:91-96. e92
• [33]Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A: Allergen-specific oral immunotherapy for peanut allergy. Cochrane Database Syst Rev 2012, 9:Cd009014.
• [34]Sheikh A, Nurmatov U, Venderbosch I, Bischoff E: Oral immunotherapy for the treatment of peanut allergy: systematic review of six case series studies. Prim Care Respir J 2012, 21:41-49.
• [35]Wang J, Sampson HA: Oral and sublingual immunotherapy for food allergy. Asian Pac J Allergy Immunol 2013, 31:198-209.
• [36]Narisety SD, Keet CA: Sublingual vs oral immunotherapy for food allergy: identifying the right approach. Drugs 2012, 72:1977-1989.
• [37]Wood RA, Sampson HA: Oral immunotherapy for the treatment of peanut allergy: is it ready for prime time? J Allergy Clin Immunol Pract 2014, 2:97-98.